AURA
Aura Biosciences, Inc.
Aura Biosciences, Inc. (AURA) has 16 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 8, 2026.
Insiders have net sold $39.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Elisabet de los Pinos
- Employees:113
- HQ:Boston, MA, US
- IPO:2021-10-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$39.2M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$727.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Gibney Anthony SFirst filing | See Remarks | Sale | 12,824 | $82K | Jun 16 | SEC ↗ |
Matrix Capital Management Company, LPFirst filing | 10% Owner | Sale | 6,922,870 | $39.0M | May 11 | SEC ↗ |
Kilroy ConorFirst filing | See Remarks | Sale | 11,738 | $82K | Apr 16 | SEC ↗ |
Related companies
Aura Biosciences, Inc. is in the Healthcare sector.